California Cancer Reporting System Standards, Volume III
Eureka Hospital Transmit
Eureka Tumor Level
Eureka Admission Level
Behavior Code ICD-O-3 [NAACCR# 523]
CS Lymph Nodes [NAACCR #2830]
CS Lymph Nodes Eval [NAACCR #2840]
CS Site-Specific Factor 2 [NAACCR #2890]
CS Site-Specific Factor 25 [NAACCR #2879]
Histologic Type ICD-O-3 [NAACCR #522]
Primary Site [NAACCR #400]
Regional Nodes Positive [NAACCR #820]
If CS Lymph Nodes = [value], CS Lymph Nodes Eval = [value], Regional Nodes Positive = [value], CS Site Specific Factor 2 must = 100, 200, or 400.
This edit checks cases coded using the SmallIntestine schema. If the CS lymph nodes indicate lymph node involvement, lymph nodes eval code indicates clinical assessment, and regional nodes positive show no nodes pathologically, then CS SSF 2 must = 100, 200, or 400 (clinical involvement of nodes).
This edit first determines the CS schema by doing a function call to the CS Dynamic Link Library (dll). The function call passes Primary Site, Histologic Type ICD-O-3, and CS Site-Specific Factor25 (schema discriminator) to the dll and the CS schema name is returned.
This edit is skipped if any of the following conditions are true:
CS Site-Specific Factor 2 is blank or 988
CS Lymph Nodes is blank
CS Lymph Nodes Eval is blank
Regional Nodes Positive is blank
Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)
CS schema is invalid
If CS schema is SmallIntestine:
If CS Lymph Nodes is 100-300 (nodes involved)
and CS Lymph Nodes Evaluation is 0, 1, 5 (clinical assessment)
and Regional nodes positive = 00, 98, or 99 (no nodes pathologically)
then CS Site-Specific Factor 2 must = 100, 200, or 400 (clinical involvement of nodes)
In the SEER*Edits software, the title of this edit is: IF368
7/27/11 | New edit for NAACCR 12.1.A. |
04/2014 | Function call to the CS Dynamic Link Library updated to call "CStage0205.dll" instead of "CStage.dll." |